Glomerulonephritis are renal inflammatory processes characterized by increased permeability of the Glomerular Filtration Barrier (GFB) with consequent hematuria and proteinuria. Glomerular endothelial cells (GEC) and podocytes are part of the GFB and contribute to the mainte-nance of its structural and functional integrity through the release of paracrine mediators. Activation of the complement cascade and pro‐inflammatory cytokines (CK) such as Tumor Necrosis Factor α (TNF‐α) and Interleukin‐6 (IL‐6) can alter GFB function, causing acute glomerular injury and progression toward chronic kidney disease. Endothelial Progenitor Cells (EPC) are bone‐marrow-derived hematopoietic stem cells circulating in peripheral blood and able to induce angiogenesis and to repair injured endothelium by releasing paracrine mediators including Extracellular Vesicles (EVs), microparticles involved in intercellular communication by transferring proteins, lipids, and genetic material (mRNA, microRNA, lncRNA) to target cells. We have previously demonstrated that EPC‐derived EVs activate an angiogenic program in quiescent endothelial cells and renopro-tection in different experimental models. The aim of the present study was to evaluate in vitro the protective effect of EPC‐derived EVs on GECs and podocytes cultured in detrimental conditions with CKs (TNF‐α/IL‐6) and the complement protein C5a. EVs were internalized in both GECs and podocytes mainly through a L‐selectin‐based mechanism. In GECs, EVs enhanced the formation of capillary‐like structures and cell migration by modulating gene expression and inducing the release of growth factors such as VEGF‐A and HGF. In the presence of CKs, and C5a, EPC‐derived EVs protected GECs from apoptosis by decreasing oxidative stress and prevented leukocyte adhesion by inhibiting the expression of adhesion molecules (ICAM‐1, VCAM‐1, E‐selectin). On podocytes, EVs inhibited apoptosis and prevented nephrin shedding induced by CKs and C5a. In a co‐culture model of GECs/podocytes that mimicked GFB, EPC‐derived EVs protected cell function and permeselectivity from inflammatory‐mediated damage. Moreover, RNase pre‐treatment of EVs ab-rogated their protective effects, suggesting the crucial role of RNA transfer from EVs to damaged glomerular cells. In conclusion, EPC‐derived EVs preserved GFB integrity from complement‐ and cytokine‐induced damage, suggesting their potential role as therapeutic agents for drug‐resistant glomerulonephritis.
Extracellular vesicles derived from endothelial progenitor cells protect human glomerular endothelial cells and podocytes from complement‐ and cytokine‐mediated injury
Franzin R.;Stasi A.;Gesualdo L.;
2021-01-01
Abstract
Glomerulonephritis are renal inflammatory processes characterized by increased permeability of the Glomerular Filtration Barrier (GFB) with consequent hematuria and proteinuria. Glomerular endothelial cells (GEC) and podocytes are part of the GFB and contribute to the mainte-nance of its structural and functional integrity through the release of paracrine mediators. Activation of the complement cascade and pro‐inflammatory cytokines (CK) such as Tumor Necrosis Factor α (TNF‐α) and Interleukin‐6 (IL‐6) can alter GFB function, causing acute glomerular injury and progression toward chronic kidney disease. Endothelial Progenitor Cells (EPC) are bone‐marrow-derived hematopoietic stem cells circulating in peripheral blood and able to induce angiogenesis and to repair injured endothelium by releasing paracrine mediators including Extracellular Vesicles (EVs), microparticles involved in intercellular communication by transferring proteins, lipids, and genetic material (mRNA, microRNA, lncRNA) to target cells. We have previously demonstrated that EPC‐derived EVs activate an angiogenic program in quiescent endothelial cells and renopro-tection in different experimental models. The aim of the present study was to evaluate in vitro the protective effect of EPC‐derived EVs on GECs and podocytes cultured in detrimental conditions with CKs (TNF‐α/IL‐6) and the complement protein C5a. EVs were internalized in both GECs and podocytes mainly through a L‐selectin‐based mechanism. In GECs, EVs enhanced the formation of capillary‐like structures and cell migration by modulating gene expression and inducing the release of growth factors such as VEGF‐A and HGF. In the presence of CKs, and C5a, EPC‐derived EVs protected GECs from apoptosis by decreasing oxidative stress and prevented leukocyte adhesion by inhibiting the expression of adhesion molecules (ICAM‐1, VCAM‐1, E‐selectin). On podocytes, EVs inhibited apoptosis and prevented nephrin shedding induced by CKs and C5a. In a co‐culture model of GECs/podocytes that mimicked GFB, EPC‐derived EVs protected cell function and permeselectivity from inflammatory‐mediated damage. Moreover, RNase pre‐treatment of EVs ab-rogated their protective effects, suggesting the crucial role of RNA transfer from EVs to damaged glomerular cells. In conclusion, EPC‐derived EVs preserved GFB integrity from complement‐ and cytokine‐induced damage, suggesting their potential role as therapeutic agents for drug‐resistant glomerulonephritis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
